No Data
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
Bitcoin Hits $98k, Nvidia Falls on Forward Guidance, Google Chrome Break-Up | Live Stock
Novo-nordisk a/s stock price returns to the starting point of the year! Sales of weight loss medication fall short of expectations, scaring off investors.
①Danish pharmaceutical company novo-nordisk a/s saw its stock price drop by over 40% from the year's high due to intensified competition in the weight loss drug market, supply restrictions, and financial reports falling below expectations; ② Novo Nordisk's CFO admitted that next year's sales growth rate may be in the tens of percent, significantly lagging behind market expectations; ③ Analysts believe that the current excessive selling sentiment towards weight loss drugs, the company still has high investment value.
Nvidia Forward Guidance Was Not Perfect, Market Flat | Wall Street Today
CDC Warns Against a Spike in COVID, Flu Cases
Eli Lilly, Verge Genomics Opt To Develop ALS Drug Candidate
I Am 102927471 :